Bolt Biotherapeutics, Inc. | Business Contracts

Clarification Letter dated April 27, 2022 between the Registrant and EirGenix, Inc (Filed With SEC on August 10, 2022)

Amended and Restated Supply Agreement between the Registrant and EirGenix, Inc., dated January 25, 2022 (Filed With SEC on May 12, 2022)

Consulting Agreement, dated March 3, 2022, by and between Bolt Biotherapeutics, Inc. and David Dornan, Ph.D (Filed With SEC on March 4, 2022)

2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)

Consent to Sublease Agreement by and between the Registrant, Armo Biosciences, Inc. and HCP LS Redwood City, LLC, dated June 14, 2019 (Filed With SEC on January 15, 2021)

Description of Securities (Filed With SEC on March 31, 2021)

Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan (Filed With SEC on February 1, 2021)

Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2021 Equity Incentive Plan (Filed With SEC on February 1, 2021)

2021 Equity Incentive Plan (Filed With SEC on February 1, 2021)

2015 Equity Incentive Plan, as amended (Filed With SEC on February 1, 2021)

Form of Underwriting Agreement (Filed With SEC on February 1, 2021)

Exclusive (Equity) Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated May 18, 2015, as amended by Amendment No. 1 to... (Filed With SEC on January 15, 2021)

Severance and Change in Control Plan (Filed With SEC on January 15, 2021)

Master Services Agreement by and between the Registrant and Piramal Healthcare UK Ltd, dated June 26, 2018 (Filed With SEC on January 15, 2021)

Supply Agreement by and between the Registrant and EirGenix, Inc., dated March 10, 2019 (Filed With SEC on January 15, 2021)

Exclusive Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated June 1, 2018 (Filed With SEC on January 15, 2021)

Form of common stock certificate of the Registrant (Filed With SEC on January 15, 2021)

Amended and Restated Investor Rights Agreement, dated June 26, 2020, by and among the Registrant and the investors listed on Schedule A thereto (Filed With SEC on January 15, 2021)

Sublease Agreement by and between the Registrant and Armo Biosciences, Inc., dated April 18, 2019 (Filed With SEC on January 15, 2021)

Lease Agreement by and between the Registrant and Metropolitan Life Insurance Company, dated August 31, 2017 (Filed With SEC on January 15, 2021)

Severance Agreement by and between the Registrant and Grant Yonehiro, dated January 26, 2017 (Filed With SEC on January 15, 2021)

Offer Letter by and between the Registrant and Grant Yonehiro, dated October 26, 2016 (Filed With SEC on January 15, 2021)

Offer Letter by and between the Registrant and Edith Perez, dated March 16, 2020 (Filed With SEC on January 15, 2021)

Offer Letter by and between the Registrant and David Dornan, dated November 29, 2017 (Filed With SEC on January 15, 2021)

Offer Letter by and between the Registrant and William Quinn, dated April 14, 2020 (Filed With SEC on January 15, 2021)

Offer of Employment by and between the Registrant and Randall C. Schatzman, dated June 10, 2019 (Filed With SEC on January 15, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)

Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on January 15, 2021)

Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

2015 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)

Britannia Seaport Centre Lease by and between the Registrant and HCP LS Redwood City, LLC, dated August 7, 2020 (Filed With SEC on January 15, 2021)

Bolt Biotherapeutics, Inc. (31)